Advancements in Research are Never a Straight Line
In this episode, Ulf Hannelius, President and CEO at Diamyd Medical gives us an inside scoop on their development of an innovative medicine for Type 1 Diabetes and explains how the path to success is often a function of tenacity, focus, and community. Ulf starts by talking about the business model, explicitly outsourcing and manufacturing, around an asset like Diamyd. He tells the story of Diamyd’s failure, the approaches they tried to bring positive results, and what they learned from them, like discovering the molecule’s effect with the right HLA haplotype.
Please tune in to learn about the research work at Dyamid and how they came back from the ashes!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
Outcomes Rocket